Aehr Test Systems Crecimiento futuro

Future controles de criterios 0/6

Se prevé que los ingresos y beneficios de Aehr Test Systems disminuyan a un ritmo anual de 2.2% y 13.7% respectivamente.

Información clave

-13.7%

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Semiconductor	11.6%
Tasa de crecimiento de los ingresos	-2.2%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	10 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

DB:AYB - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
5/31/2025	68	12	N/A	N/A	2
5/31/2024	65	12	N/A	N/A	2
2/29/2024	72	15	5	6	N/A
11/30/2023	82	21	6	8	N/A
8/31/2023	75	19	7	8	N/A
5/31/2023	65	15	9	10	N/A
2/28/2023	63	14	3	3	N/A
11/30/2022	61	12	1	2	N/A
8/31/2022	56	9	5	5	N/A
5/31/2022	51	9	1	2	N/A
2/28/2022	38	4	2	2	N/A
11/30/2021	28	1	5	5	N/A
8/31/2021	20	-1	-2	-1	N/A
5/31/2021	17	-2	-3	-3	N/A
2/28/2021	13	-5	-4	-4	N/A
11/30/2020	14	-4	-4	-4	N/A
8/31/2020	19	-2	-1	-1	N/A
5/31/2020	22	-3	-2	-2	N/A
2/29/2020	26	0	-2	-1	N/A
11/30/2019	23	-3	-3	-3	N/A
8/31/2019	22	-4	-5	-5	N/A
5/31/2019	21	-5	-6	-6	N/A
2/28/2019	21	-5	-3	-3	N/A
11/30/2018	25	-2	-3	-2	N/A
8/31/2018	27	-1	1	2	N/A
5/31/2018	30	1	-2	-1	N/A
2/28/2018	29	0	-4	-3	N/A
11/30/2017	24	-3	N/A	-5	N/A
8/31/2017	21	-5	N/A	-10	N/A
5/31/2017	19	-6	N/A	-4	N/A
2/28/2017	14	-8	N/A	-6	N/A
11/30/2016	13	-8	N/A	-4	N/A
8/31/2016	13	-8	N/A	-3	N/A
5/31/2016	15	-7	N/A	-6	N/A
2/29/2016	15	-6	N/A	-5	N/A
11/30/2015	15	-4	N/A	-5	N/A
8/31/2015	13	-5	N/A	-4	N/A
5/31/2015	10	-7	N/A	-2	N/A
2/28/2015	14	-5	N/A	-2	N/A
11/30/2014	17	-3	N/A	-2	N/A
8/31/2014	19	0	N/A	-1	N/A
5/31/2014	20	0	N/A	-1	N/A
2/28/2014	18	-1	N/A	0	N/A
11/30/2013	15	-2	N/A	1	N/A
8/31/2013	15	-3	N/A	0	N/A
5/31/2013	16	-3	N/A	0	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de AYB disminuyan en los próximos 3 años (-13.7% al año).

Beneficios vs. Mercado: Se prevé que los beneficios de AYB disminuyan en los próximos 3 años (-13.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de AYB disminuyan en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de AYB disminuyan en los próximos 3 años (-2.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de AYB disminuyan en los próximos 3 años (-2.2% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de AYB se prevé que sea elevada dentro de 3 años.

Aehr Test Systems Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023

Aehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023

Recent updates

Now 22% overvalued

New major risk - Revenue and earnings growth

Now 25% overvalued

Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Investor sentiment deteriorates as stock falls 16%

Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 17%

New minor risk - Insider selling

President recently sold €78k worth of stock

Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Investor sentiment deteriorates as stock falls 16%

Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee

Investor sentiment deteriorates as stock falls 18%

First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023

Aehr Test Systems, Annual General Meeting, Oct 23, 2023

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Investor sentiment deteriorates as stock falls 17%

President recently sold €5.7m worth of stock

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Aehr Test Systems to Report Q4, 2023 Results on Jul 13, 2023

Aehr Test Systems Appoints Chris Siu, as Chief Financial Officer Effective June 1, 2023

Investor sentiment improves as stock rises 19%

Investor sentiment deteriorates as stock falls 21%

Independent Director recently sold €775k worth of stock

Investor sentiment deteriorates as stock falls 26%

Third quarter 2023 earnings released: EPS: US$0.15 (vs US$0.083 in 3Q 2022)

Investor sentiment improves as stock rises 33%

Investor sentiment improves as stock rises 20%

Insider recently sold €1.2m worth of stock

Aehr Test Systems Announces Board Changes

Investor sentiment improves as stock rises 27%

Independent Director recently sold €381k worth of stock

Investor sentiment improved over the past week

Aehr Test Systems Reiterates Revenue Guidance for the Fiscal Year Ending May 31, 2023

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.027 in 2Q 2022)

Aehr Test Systems to Report Q2, 2023 Results on Jan 05, 2023

President recently sold €1.7m worth of stock

Investor sentiment improved over the past week

Vice President of Engineering recently sold €463k worth of stock

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: US$0.022 (vs US$0.029 in 1Q 2022)

Aehr Test Systems Provides Revenue Guidance for the Fiscal Year Ending May 31, 2023

Investor sentiment deteriorated over the past week

Aehr Test Systems, Annual General Meeting, Oct 18, 2022

Aehr Test Systems to Report Q1, 2023 Results on Oct 06, 2022

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)

Investor sentiment improved over the past week

Independent Director recently sold €123k worth of stock

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: US$0.36 (vs US$0.086 loss in FY 2021)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year 2023

Aehr Test Systems to Report Fiscal Year 2022 Results on Jul 19, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Aehr Test Systems Appoints Adil Engineer as the Chief Operating Officer, Effective April 6, 2022

Third quarter 2022 earnings released: EPS: US$0.083 (vs US$0.031 loss in 3Q 2021)

Aehr Test Systems Reiterates Financial Guidance the Fiscal Year Ending May 31, 2022

Aehr Test Systems to Report Q3, 2022 Results on Mar 31, 2022

Vice President of Operations recently sold €133k worth of stock

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2022

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Independent Director recently sold €1.1m worth of stock